Literature DB >> 16503824

Emerging new drugs for wound repair.

Karen Meier1, Lillian B Nanney.   

Abstract

Every year, millions of people experience burns, suffer from nonhealing wounds, or have acute wounds that become complicated by infection, dehiscence or problematic scarring. Effective wound treatment requires carefully considered interventions often requiring multiple clinic or hospital visits. The resulting costs of wound care are staggering, and more efficacious and cost-effective therapies are needed to decrease this burden. Unfortunately, the expenses and difficulties encountered in performing clinical trials have led to a relatively slow growth of new treatment options for the wound management. Research efforts attempting to examine wound pathophysiology have been hampered by the lack of an adequate chronic wound healing model, and the complexity of the wound healing cascade has limited attempts at pharmacological modification. As such, currently available wound healing therapies are only partially effective. Therefore, many new therapies are emerging that target various aspects of wound repair and the promise of new therapeutic interventions is on the immediate horizon.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503824     DOI: 10.1517/14728214.11.1.23

Source DB:  PubMed          Journal:  Expert Opin Emerg Drugs        ISSN: 1472-8214            Impact factor:   4.191


  14 in total

Review 1.  Redox signals in wound healing.

Authors:  Chandan K Sen; Sashwati Roy
Journal:  Biochim Biophys Acta       Date:  2008-01-18

2.  Calreticulin enhances porcine wound repair by diverse biological effects.

Authors:  Lillian B Nanney; Christopher D Woodrell; Mathew R Greives; Nancy L Cardwell; Alonda C Pollins; Tara A Bancroft; Adrianne Chesser; Marek Michalak; Mohammad Rahman; John W Siebert; Leslie I Gold
Journal:  Am J Pathol       Date:  2008-09       Impact factor: 4.307

3.  Wound healing activities of different extracts of Centella asiatica in incision and burn wound models: an experimental animal study.

Authors:  Juraiporn Somboonwong; Mattana Kankaisre; Boonyong Tantisira; Mayuree H Tantisira
Journal:  BMC Complement Altern Med       Date:  2012-07-20       Impact factor: 3.659

4.  Evaluation of wound healing and anti-inflammatory activity of the rhizomes of Rumex abyssinicus J. (Polygonaceae) in mice.

Authors:  Eshetu Mulisa; Kaleab Asres; Ephrem Engidawork
Journal:  BMC Complement Altern Med       Date:  2015-09-30       Impact factor: 3.659

5.  Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis.

Authors:  Corine E Delsing; Katharina L Becker; Anna Simon; Bart Jan Kullberg; Chantal P Bleeker-Rovers; Frank L van de Veerdonk; Mihai G Netea
Journal:  BMC Infect Dis       Date:  2015-03-21       Impact factor: 3.090

Review 6.  Inflammation in Chronic Wounds.

Authors:  Ruilong Zhao; Helena Liang; Elizabeth Clarke; Christopher Jackson; Meilang Xue
Journal:  Int J Mol Sci       Date:  2016-12-11       Impact factor: 5.923

Review 7.  Fibroblast growth factors in the management of spinal cord injury.

Authors:  Yulong Zhou; Zhouguang Wang; Jiawei Li; Xiaokun Li; Jian Xiao
Journal:  J Cell Mol Med       Date:  2017-10-24       Impact factor: 5.310

8.  Bacterial Isolates and Their Antimicrobial Susceptibility Patterns of Wound Infections among Inpatients and Outpatients Attending the University of Gondar Referral Hospital, Northwest Ethiopia.

Authors:  Aynalem Mohammed; Mengistu Endris Seid; Teklay Gebrecherkos; Moges Tiruneh; Feleke Moges
Journal:  Int J Microbiol       Date:  2017-03-12

9.  Biologics in dermatologic therapy - an update.

Authors:  Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

10.  Exogenous administration of a recombinant variant of TWEAK impairs healing after myocardial infarction by aggravation of inflammation.

Authors:  Christina Pachel; Denise Mathes; Barbara Bayer; Charlotte Dienesch; Gaby Wangorsch; Wolfram Heitzmann; Isabell Lang; Hossein Ardehali; Georg Ertl; Thomas Dandekar; Harald Wajant; Stefan Frantz
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.